» Articles » PMID: 39085503

Serial Diffusion Tensor Imaging and Rate of Ventricular Blood Clearance in Patients with Intraventricular Hemorrhage

Abstract

Background: We developed a noninvasive biomarker to quantify the rate of ventricular blood clearance in patients with intracerebral hemorrhage and extension to the ventricles-intraventricular hemorrhage.

Methods: We performed magnetic resonance imaging in 26 patients at 1, 14, 28, and 42 days of onset and measured their hematoma volume (HV), ventricular blood volume (VBV), and two diffusion metrics: fractional anisotropy (FA), and mean diffusivity (MD). The ipasilesional ventricular cerebral spinal fluid's FA and MD were associated with VBV and stroke severity scores (National Institute of Health Stroke Scale [NIHSS]). A subcohort of 14 patients were treated with external ventricular drain (EVD). A generalized linear mixed model was applied for statistical analysis.

Results: At day 1, the average HVs and NIHSS scores were 14.6 ± 16.7 cm and 16 ± 8, respectively. A daily rate of 2.1% and 1.3% blood clearance/resolution were recorded in HV and VBV, respectively. Ipsilesional ventricular FA (vFA) and ventricular MD (vMD) were simultaneously decreased (vFA = 1.3% per day, posterior probability [PP] > 99%) and increased (vMD = 1.5% per day, PP > 99%), respectively. Patients with EVD exhibited a faster decline in vFA (1.5% vs. 1.1% per day) and an increase in vMD (1.8% vs. 1.5% per day) as compared with patients without EVD. Temporal change in vMD was associated with VBV; a 1.00-cm increase in VBV resulted in a 5.2% decrease in vMD (PP < 99%). VBV was strongly associated with NIHSS score (PP = 97-99%). A larger cerebral spinal fluid drained volume was associated with a greater decrease (PP = 83.4%) in vFA, whereas a smaller volume exhibited a greater increase (PP = 94.8%) in vMD.

Conclusions: In conclusion, vFA and vMD may serve as biomarkers for VBV status.

References
1.
An S, Kim T, Yoon B . Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update. J Stroke. 2017; 19(1):3-10. PMC: 5307940. DOI: 10.5853/jos.2016.00864. View

2.
Feigin V, Lawes C, Bennett D, Barker-Collo S, Parag V . Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 2009; 8(4):355-69. DOI: 10.1016/S1474-4422(09)70025-0. View

3.
Keep R, Hua Y, Xi G . Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol. 2012; 11(8):720-31. PMC: 3884550. DOI: 10.1016/S1474-4422(12)70104-7. View

4.
Xi G, Keep R, Hoff J . Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol. 2005; 5(1):53-63. DOI: 10.1016/S1474-4422(05)70283-0. View

5.
Jolink W, Klijn C, Brouwers P, Kappelle L, Vaartjes I . Time trends in incidence, case fatality, and mortality of intracerebral hemorrhage. Neurology. 2015; 85(15):1318-24. DOI: 10.1212/WNL.0000000000002015. View